{"id":"https://openalex.org/W73444543","doi":null,"title":"Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracil.","display_name":"Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracil.","alternate_titles":[],"publication_year":2001,"publication_date":"2001-05-01","ids":{"openalex":"https://openalex.org/W73444543","mag":"73444543","pmid":"https://pubmed.ncbi.nlm.nih.gov/11497250"},"language":"en","primary_location":{"id":"pmid:11497250","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11497250","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W73444543"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031542980","display_name":"Toshiyuki Kato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120269","display_name":"Taiho Pharmaceutical (Japan)","ror":"https://ror.org/02v50dx14","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210120269"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T Kato","raw_affiliation_strings":["The Second Cancer Laboratory, Taiho Pharmaceutical Co. Ltd., Hanno-City, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Second Cancer Laboratory, Taiho Pharmaceutical Co. Ltd., Hanno-City, Saitama, Japan","institution_ids":["https://openalex.org/I4210120269"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071027771","display_name":"Yuji Shimamoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y Shimamoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001730366","display_name":"Junji Uchida","orcid":"https://orcid.org/0000-0002-0113-8058","observed_orcids":["https://orcid.org/0000-0002-0113-8058"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Uchida","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036204294","display_name":"Hideyuki Ohshimo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Ohshimo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M Abe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Abe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113793342","display_name":"Tetsuhiko Shirasaka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Shirasaka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5112318990","display_name":"Masakazu Fukushima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Fukushima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5237,"has_fulltext":false,"cited_by_count":33,"citation_normalized_percentile":{"value":0.65634933,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"21","issue":"3B","first_page":"1705","last_page":"1712"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.367900013923645,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.367900013923645,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.14110000431537628,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.12449999898672104,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/s-1","display_name":"S-1","score":0.9769999980926514},{"id":"https://openalex.org/keywords/tegafur","display_name":"tegafur","score":0.8019999861717224},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9509999752044678},{"id":"https://openalex.org/keywords/potassium-oxonate","display_name":"potassium oxonate","score":0.9919999837875366},{"id":"https://openalex.org/keywords/5-fluorouracil-metabolism","display_name":"5-fluorouracil metabolism","score":0.8159999847412109},{"id":"https://openalex.org/keywords/stomatitis","display_name":"stomatitis","score":0.6330000162124634},{"id":"https://openalex.org/keywords/oral-mucositis","display_name":"oral mucositis","score":0.7910000085830688},{"id":"https://openalex.org/keywords/pentylenetetrazole-induced-seizures","display_name":"pentylenetetrazole-induced seizures","score":0.8659999966621399},{"id":"https://openalex.org/keywords/fluoroacetate","display_name":"fluoroacetate","score":0.8429999947547913}],"concepts":[{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.8211371898651123},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.7700502872467041},{"id":"https://openalex.org/C2779051857","wikidata":"https://www.wikidata.org/wiki/Q911386","display_name":"Stomatitis","level":2,"score":0.7255447506904602},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7098230123519897},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.6518714427947998},{"id":"https://openalex.org/C2777299880","wikidata":"https://www.wikidata.org/wiki/Q413370","display_name":"Tegafur","level":3,"score":0.6235336065292358},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5600656270980835},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5404556393623352},{"id":"https://openalex.org/C2779491297","wikidata":"https://www.wikidata.org/wiki/Q3338704","display_name":"Neurotoxicity","level":3,"score":0.45405274629592896},{"id":"https://openalex.org/C2777010014","wikidata":"https://www.wikidata.org/wiki/Q852376","display_name":"Convulsion","level":3,"score":0.4236918091773987},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31418266892433167},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26291781663894653},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.09649839997291565},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000855","descriptor_name":"Anorexia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002250","descriptor_name":"Carbon Radioisotopes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005463","descriptor_name":"Fluoroacetates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005641","descriptor_name":"Tegafur","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005641","descriptor_name":"Tegafur","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008813","descriptor_name":"Mice, Inbred ICR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009061","descriptor_name":"Mouth Mucosa","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009061","descriptor_name":"Mouth Mucosa","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009061","descriptor_name":"Mouth Mucosa","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010094","descriptor_name":"Oxonic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010094","descriptor_name":"Oxonic Acid","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D010433","descriptor_name":"Pentylenetetrazole","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014839","descriptor_name":"Vomiting","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11497250","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11497250","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:73444543","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11497250","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2077902459","https://openalex.org/W2153244200","https://openalex.org/W2035456243","https://openalex.org/W2316711778","https://openalex.org/W2032540605","https://openalex.org/W655595061","https://openalex.org/W2046052198","https://openalex.org/W2027678619","https://openalex.org/W2079280112"],"abstract_inverted_index":{"S-1":[0,148,169,195,220,243],"is":[1,222],"a":[2,30,66,80,134],"new":[3,67],"oral":[4,219,236,242],"formulation":[5],"of":[6,51,58,64,69,76,82,89,105,109,113,126,137,139,144,147,156,168,181,194,207,211,215,226,234,250,259],"5-fluorouracil":[7],"(5-FU)":[8],"containing":[9,197],"1":[10,19],"M":[11,15,20],"tegafur":[12],"and":[13,18,34,42,72,96,264],"0.4":[14],"5-chloro-2,4-dihydroxypyridine":[16],"(CDHP)":[17],"potassium":[21],"oxonate":[22],"(Oxo).":[23],"It":[24],"has":[25],"been":[26],"reported":[27],"to":[28,133,173,186],"have":[29],"high":[31],"antitumor":[32],"activity":[33],"low":[35],"gastrointestinal":[36],"toxicity":[37],"in":[38,85,162,188,199,230,256],"rats":[39],"bearing":[40],"murine":[41],"human":[43],"tumors.":[44],"We":[45],"further":[46],"studied":[47],"the":[48,52,56,62,103,120,145,154,179,191,208,212,223,231,235,248,257],"possible":[49,209],"inhibition":[50,125],"toxicities":[53,260],"caused":[54],"by":[55,129],"products":[57],"5-FU":[59,70,77,97,116,127,140,229],"metabolism":[60],"with":[61,115,218,253],"use":[63,146],"CDHP,":[65],"inhibitor":[68,75],"degradation":[71],"Oxo,":[73,198],"an":[74,110],"phosphorylation.":[78],"In":[79],"model":[81],"pentylenetetrazole-induced":[83],"convulsions":[84],"mice,":[86],"intravenous":[87],"injection":[88],"fluoroacetate":[90],"(3":[91],"mg/kg),":[92],"2-fluoro-b-alanine":[93],"(30":[94],"mg/kg)":[95,100],"(over":[98],"300":[99],"significantly":[101],"augmented":[102],"occurrence":[104],"convulsion.":[106],"However":[107],"coadministration":[108],"equivalent":[111],"dose":[112,193],"CDHP":[114,130],"almost":[117],"completely":[118],"suppressed":[119],"5-FU-augmented":[121],"convulsions,":[122],"suggesting":[123],"that":[124,187,241],"catabolism":[128],"may":[131],"lead":[132],"decreased":[135,183,213,224],"risk":[136],"development":[138,155],"neurotoxicity.":[141],"Another":[142],"advantage":[143],"was":[149,170,203],"protection":[150],"through":[151],"Oxo":[152],"against":[153],"5-FU-induced":[157],"mucositis,":[158],"which":[159,200],"occurs":[160],"frequently":[161,204],"cancer":[163,251],"patients.":[164],"When":[165],"6":[166],"mg/kg":[167],"administered":[171],"orally":[172],"beagle":[174],"dogs":[175,189],"for":[176,247],"5":[177],"days,":[178],"incidence":[180,214,258],"stomatitis":[182,202,263],"markedly":[184],"compared":[185],"receiving":[190],"same":[192],"not":[196],"severe":[201],"observed.":[205],"One":[206],"mechanisms":[210],"mucositis":[216],"associated":[217],"administration":[221],"formation":[225],"5-fluoronucleotides":[227],"from":[228],"mucosal":[232],"tissues":[233],"cavity.":[237],"These":[238],"results":[239],"suggest":[240],"could":[244],"be":[245],"employed":[246],"treatment":[249],"patients":[252],"marked":[254],"reduction":[255],"including":[261],"encephalopathy,":[262],"diarrhea.":[265]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W73444543","counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
